Published in Vaccine Weekly, October 22nd, 2003
Mice protected by a single dose of one of Avanir's lead antibodies, AVP-8C1, against a lethal challenge of anthrax spores, were still completely protected on subsequent exposure to anthrax spores 4 weeks later. The immediate immunity conferred by the antibody appears to assist in the establishment of long-lasting immunity.
Phillip R. Morrow, PhD, co-inventor of Avanir's Xenerex technology and featured speaker at the Biophex conference, presented data in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly